|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Genetic Technologies Ltd. (GENE) |
|
|
$0.52 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
13,770,000 |
| Market
Cap: |
7.16(M) |
| Last
Volume: |
166,888 |
Avg
Vol: |
166,437 |
| 52
Week Range: |
$0.52 - $0.52 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Genetic Technologies is a molecular diagnostics company that provides predictive testing and assessment tools to help physicians manage women's health. Co.'s key product, BREVAGenplus, was a clinically validated risk assessment test for non-hereditary breast cancer. Co. has launched the first generation BREVAGen test across the U.S. via its U.S. subsidiary Phenogen Sciences Inc. Co. has developed two new cancer risk assessment tests branded as GeneType for Colorectal Cancer and GeneType for Breast Cancer. Co. also develops other risk assessment tests across a range of diseases, including cardiovascular disease, type 2 diabetes, prostate cancer and melanoma.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Gigliotti Robert S |
Director |
– • – |
2003-07-15 |
4 |
A |
$0.03 |
$1,075 |
D/D |
43,000 |
656,000 |
|
- |
|
| Baker Harvey |
officerTitle |
• – – |
2003-07-08 |
4 |
B |
$2.30 |
$900 |
D/D |
392 |
3,157 |
2.74 |
- |
|
| Harington Allen |
Director |
– • • |
2001-06-20 |
5 |
A |
$0.00 |
$10,000 |
I/I |
10,000,000 |
10,000,000 |
|
- |
|
| Baratta Robert O Md |
Chief Executive Officer |
• • – |
2000-08-16 |
4 |
B |
$12.50 |
$2,500 |
D/D |
200 |
200 |
2.81 |
- |
|
| Lampropoulos Fred P |
Chairman, President, CEO |
• • • |
1988-08-08 |
4 |
A |
$20.00 |
$593,120 |
I/I |
29,656 |
29,656 |
|
- |
|
| Stanger Kent W |
Chief Financial Officer |
• • – |
1988-08-08 |
4 |
A |
$4.77 |
$521,560 |
I/I |
109,351 |
26,078 |
|
- |
|
181 Records found
|
|
Page 8 of 8 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
